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The 15-kD proliferating cell nuclear antigen (PCNA)-
associated factor (Paf) was originally identified in a 
yeast two-hybrid screen to identify novel PCNA-
interacting proteins (Yu et al., 2001). PAF inter-
acts with PCNA via a conserved PCNA binding 
motif and localizes to the nucleus in cell lines (Yu 
et al., 2001; Simpson et al., 2006; Hosokawa et al., 
2007). PAF interacts with the DNA polymerase  
p125 subunit and flap endonuclease-1, and Paf 
expression triggers the DNA repair machinery 
after UV-induced DNA damage (Hosokawa   
et al., 2007; Turchi et al., 2009). Thus, it has been 
proposed that the biological function of Paf may 
be linked to one or more of the functions of 
PCNA, which has essential roles in DNA replica-
tion and repair and cell cycle control (Maga and 
Hubscher, 2003). However, cell line–based studies 
have also implicated Paf in such diverse processes 
as cell survival and proliferation. (Mizutani et al., 
2005; Simpson et al., 2006; Guo et al., 2006; 
Hosokawa et al., 2007; Turchi et al., 2009).
Much effort has gone into identifying genes 
that are differentially expressed in cancer relative 
to normal tissues. These analyses have shown 
that Paf mRNA levels are overexpressed in many 
cancers (Yu et al., 2001; Petroziello et al., 2004; 
Mizutani et al., 2005; Marie et al., 2008) and in-
creased Paf mRNA levels are part of a common 
cancer signature comprised of 46 genes (Xu   
et al., 2007). Paf also transforms NIH3T3 cells 
into tumor cells in a xenograft model (Hosokawa 
et al., 2007). Thus, Paf is overexpressed in tumors 
and has oncogenic potential. Cancer cells and 
hematopoietic stem cells (HSCs) share the abil-
ity to self-renew; thus, the genes and pathways 
associated with malignancies often also regulate 
HSC  function  (Reya  et  al.,  2001).  Here,  we 
show that genetic disruption of Paf by homolo-
gous recombination in mice resulted in altered 
HSC function, disrupted progenitor development, 
and leukopenia.
CORRESPONDENCE  
Lisa K. Denzin:  
denzinl@mskcc.org
Abbreviations used: CLP, 
common lymphoid progenitor; 
CMP, common myeloid pro-
genitor; ETP, early thymic 
progenitor; GMP, granulocyte-
macrophage progenitor; HSC, 
hematopoietic stem cell; Lin, 
lineage; LSK, Lin Sca-1+,  
c-KitHigh; LSK, Lin Sca-1  
c-KitHigh; LT, long-term; LMPP, 
lymphoid-primed MPP; MEP, 
megakaryocyte-erythroid 
progenitor; MFI, mean  
fluorescence intensity; MPP, 
multipotent progenitor; NAC, 
N-acetylcysteine; Paf, 15-kD 
PCNA-associated factor; PCNA, 
proliferating cell nuclear antigen; 
ROS, reactive oxygen species; 
ST, short-term.
The Paf oncogene is essential for 
hematopoietic stem cell function  
and development
Yacine M. Amrani,1 Jonathan Gill,3 Armine Matevossian,4 Eric S. Alonzo,4 
Chingwen Yang,6 Jae-Hung Shieh,2 Malcolm A. Moore,2,4  
Christopher Y. Park,5 Derek B. Sant’Angelo,1,4 and Lisa K. Denzin1,4
1Immunology Program and 2Cell Biology Program, Sloan-Kettering Institute, 3Department of Pediatrics, 4Gerstner Sloan-
Kettering Graduate School of Biomedical Sciences, and 5Human Oncology and Pathogenesis Program, Department  
of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10065,
6Gene Targeting Resource Center, The Rockefeller University, New York, NY 10065
Hematopoietic stem cells (HSCs) self-renew to maintain the lifelong production of all blood 
populations. Here, we show that the proliferating cell nuclear antigen–associated factor 
(Paf) is highly expressed in cycling bone marrow HSCs and plays a critical role in hemato-
poiesis. Mice lacking Paf exhibited reduced bone marrow cellularity; reduced numbers of 
HSCs and committed progenitors; and leukopenia. These phenotypes are caused by a cell-
intrinsic blockage in the development of long-term (LT)-HSCs into multipotent progenitors 
and preferential loss of lymphoid progenitors caused by markedly increased p53-mediated 
apoptosis. In addition, LT-HSCs from Paf/ mice had increased levels of reactive oxygen 
species (ROS), failed to maintain quiescence, and were unable to support LT hematopoiesis. 
The loss of lymphoid progenitors was likely due the increased levels of ROS in LT-HSCs 
caused by treatment of Paf/ mice with the anti-oxidant N-acetylcysteine restored lym-
phoid progenitor numbers to that of Paf+/+ mice. Collectively, our studies identify Paf as  
a novel and essential regulator of early hematopoiesis.
© 2011 Amrani et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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in all other organs examined, albeit to different levels. CD8 
single-positive thymocytes exhibited the highest level of mRNA 
expression among the analyzed lymphocyte populations. 
Furthermore, all thymocyte subsets expressed higher Paf tran-
script levels than splenic lymphocytes and DCs (Fig. S1 A). 
However, high mRNA expression levels did 
not correlate with high PAF protein levels, 
supporting  that  posttranslational  mecha-
nisms regulate PAF expression (Fig. S2 C).
To  elucidate  Paf  function  in  hemato-
poietic and lymphocyte development, Paf/ 
mice were generated (Fig. S1 B). Paf inac-
tivation was confirmed by Southern blot, 
RT-PCR, immunoblot and FACS analysis 
of thymocytes from Paf+/+ and Paf/ mice 
(Fig.  1  A;  Fig.  S1,  C  and  D;  and  not 
depicted). Although the Paf gene is embed-
ded within the thyroid hormone receptor inter-
acting protein 4 locus, mRNA expression was 
not altered in Paf/ mice (Fig. S1 E).
Paf/ mice had reduced thymic, splenic 
and BM cellularity that did not self-correct 
with aging (Fig. 1 B). Total white blood cell 
counts were also reduced (Fig. S1 F).
Paf is necessary for proper HSC  
and progenitor development
The leukopenia in Paf/ mice might be 
caused by insufficient hematopoietic BM 
progenitors,  which  mainly  reside  within 
the BM lineage (Lin) Sca-1+ c-KitHigh 
(LSK) population. Paf/ mice (8 wk old) 
had lower percentages of LSKs among total 
RESULTS AND DISCUSSION
Paf/ mice are leukopenic
We first examined Paf gene expression in various organs and 
cells by real-time PCR. Paf mRNA was most highly expressed 
in the thymus, although message expression was also detected 
Figure 1.  Paf is necessary for proper HSC and 
progenitor development. (A) FACS of thymocytes 
from Paf+/+ and Paf/ mice stained for intracel-
lular PAF. (B) Total number of cells in BM, thymuses, 
and spleens of Paf+/+ and Paf/ mice. (C) Repre-
sentative staining profiles for BM HSC and progeni-
tor populations. (D and E) Absolute cell numbers in 
the BM of 8-wk-old (D) or 6-mo-old (E) Paf+/+ and 
Paf/ mice. (F) Representative staining profiles 
and absolute number of CLPs in the BM of 8-wk- 
and 6-mo-old mice. Plots are gated for LinSca-1low 
c-kitlow cells as defined in (C). (G) Representative 
staining profiles and absolute cell numbers of ETPs 
in the thymus of 8-wk-old mice. (H) Representative 
staining profiles for myeloerythroid progenitors. 
LSK cells (defined in C) were subdivided into 
CMPs, GMPs, and MEPs as indicated. (I and J).  
Absolute cell numbers of LSKs, CMPs, GMPs, and 
MEPs in the BM of 8-wk-old (I) or 6-mo-old (J) 
mice. Each symbol represents a mouse combined 
from 3–6 experiments. Horizontal bars indicate the 
mean. Numbers in parentheses are the fold change 
of cell numbers for Paf/ relative to Paf+/+ mice.  
*, P < 0.05; **, P < 0.01; ***, P < 0.001.JEM Vol. 208, No. 9  1759
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Overexpression and knockdown studies in cell lines have 
shown that Paf promotes or impedes cellular proliferation, 
respectively (Petroziello et al., 2004; Mizutani et al., 2005;   
Hosokawa et al., 2007). Thus, progenitor populations might 
be diminished because of a requirement for Paf for progenitor 
cell  expansion.  Unexpectedly,  the  proportion  of  Paf/ 
BM LSKs present in the S–G2–M phases of the cell cycle was 
significantly increased (Fig. 2 B and Fig. S2 D). All LSK HSC 
subsets and progenitor populations showed higher propor-
tions of cycling cells. The largest difference was observed for 
Paf/ LT-HSCs (1.8-fold). In contrast, Paf/ and Paf+/+ LSK 
subpopulations cycled at similar frequencies.
BM HSC populations were also examined after 24 h of   
in vivo BrdU labeling (Fig. 2, C and D and Fig. S2 E). Paf/ 
LSK populations and CLPs incorporated significantly more 
BrdU than their Paf+/+ counterparts. As observed for the di-
rect cell cycle analyses (Fig. 2 B), LT-HSCs showed the largest 
difference (twofold). Total Paf/ LSK cells, CMPs/GMPs 
and MEPs also incorporated significantly more BrdU than 
Paf+/+ LSK populations, but the difference was not as large 
as that observed for LSK populations. Collectively, these data 
show that reduced HSCs and progenitors in Paf/ BM was 
likely not caused by decreased cycling. Instead, these data sup-
port a role for Paf in restraining the cycling of BM HSCs and, 
in particular, in restricting LT-HSC proliferation.
These  data  suggested  that  the  profound  deficiency  of 
LMPPs and CLPs in Paf/ mice was more likely caused by 
increased apoptosis. The frequency of cells that were under-
going apoptosis (DAPIAnnexinV+) were similar for Paf+/+ 
and Paf/ total LSKs and LSKs (Fig. 2, E and F). However, 
analysis of HSCs and progenitors showed a significant increase 
in the frequency of apoptotic LMPPs (1.7-fold) and CLPs 
(2.5-fold). Thus, LMPPs and CLPs are likely diminished in 
the BM of Paf/ mice because of increased apoptosis. The 
increased cell death was restricted to early lymphoid progeni-
tors because enhanced cell death is not observed in other cell 
populations, including developing, mature and activated B 
and T cells (Fig. S2 G and not depicted).
To determine if the p53 pathway plays a role in Paf/ 
progenitor cell death, Paf/ mice were crossed with p53/ 
mice to generate Paf/p53+/ mice. Paf/ that lacked one 
copy of p53 had increased frequencies and absolute cell num-
bers of LMPPs when compared with Paf/p53+/+ mice (Fig. 2, 
G and H). Thus, Paf / LMPP death is caused, at least in part, 
by p53-mediated apoptosis.
Paf controls LT-HSC quiescence
Cellular quiescence is an essential mechanism by which the 
LT self-renewal potential of BM HSCs is maintained (Orford 
and Scadden, 2008). Because Paf/ HSCs were more ac-
tively cycling, Paf might contribute to the maintenance of 
LT-HSC quiescence. The frequency of quiescent LT-HSCs 
(Ki-67) was significantly reduced in Paf/ mice (Fig. 3, A 
and B). Moreover, Paf deficiency resulted in reduced fre-
quencies of Ki-67 (G0) cells for all other LSK progenitor 
subsets, but not for LSKs or LSK subsets (Fig. 3, A and B; 
BM cells, which resulted in a two to eightfold reduction in 
the absolute number of LSKs (Fig. 1, C and D). LSKs can be 
separated into HSCs and progenitors on the basis of CD34 
and  Flt-3  expression.  CD34Flt-3  cells  are  enriched  for 
long-term (LT)-HSCs, CD34+Flt-3 cells comprise short-
term (ST)-HSCs, cells with intermediate levels of Flt-3 are 
multipotent progenitors (MPPs), and the Flt-3bright cells are 
lymphoid-primed  MPPs  (LMPPs; Adolfsson  et  al.,  2001). 
Paf/ BM LSKs contained increased frequencies of LT- and 
ST-HSCs, but severely reduced frequencies of LMPPs. When 
the  frequencies  were  converted  to  absolute  cell  numbers, 
there was a marked reduction of each population caused by 
the overall reduced BM cellularity. MPPs (4.1-fold) and 
LMPPs (10.2-fold) had the largest decrease in cell numbers 
(Fig. 1 D). The reduction in HSCs and progenitors in Paf/ 
mice was maintained in 6-mo-old mice (Fig. 1 E). The BM of 
older Paf/ mice showed a more severe and significant loss 
of LT-HSCs suggesting that Paf may be necessary for main-
taining LT-HSCs.
Further differentiation of MPPs and LMPPs gives rise to 
common lymphoid progenitors (CLPs) in the BM (Kondo et al., 
1997) and early thymic progenitors (ETPs) in the thymus (Chi   
et al., 2009). Consistent with the loss of MPPs and LMPPs in 
Paf/ mice, a significant reduction in the frequency and absolute 
numbers of CLPs and ETPs was also observed (Fig. 1, F and G).
Myeloerythroid progenitors are derived from LSK cells 
and are contained in the Lin Sca-1c-Kit+ (LSK) BM pop-
ulation. They can be further divided based upon CD34 and 
FcRIII/II (CD16/32) expression into common myeloid pro-
genitors (CMP; CD34+ FcRII/IIlow), granulocyte-macrophage 
progenitors (GMP; CD34+ FcRII/IIhigh), and megakaryo-
cyte-erythroid progenitors (MEP; CD34 FcRIII/IIlow; 
Akashi et al., 2000). BM from 8-wk-old Paf/ mice had 
lower frequencies of LSK cells (Fig. 1 C), which resulted in 
a small, but significant, decrease (1.4-fold) in the absolute 
numbers (Fig. 1 I). This decrease was caused by reduced num-
bers of CMPs (2.2-fold) and GMPs (1.6-fold), but not MEPs 
(Fig. 1, H and I). In older Paf/ mice, the LSK cells and GMPs 
and CMPs were present at near normal numbers (Fig. 1 J). 
However, MEPs were present at significantly higher numbers, 
although this difference was less than twofold (Fig. 1 J). Thus, 
myeloerythroid progenitors are also impacted by the loss of 
Paf, but to a lesser extent than lymphoid progenitors.
Paf restrains HSC, MPP, and LMPP proliferation and protects 
LMPPs and CLPs from p53-mediated apoptosis
An analysis of PAF protein expression in BM HSCs and pro-
genitors showed that all LSK and LSK subsets expressed PAF 
and  that  PAF  protein  expression  was  detected  mainly  in   
cycling cells (Fig. 2 A and Fig. S2, B and C). Consistent with 
the profound reduction of CLPs in Paf/ mice, CLPs had 
the highest overall level of PAF (mean fluorescence intensity 
[MFI] = 12,392). LT-HSCs are, for the most part, quiescent 
cells. Thus, it was unexpected to find that the small number of 
cycling or cell cycle arrested LT-HSCs also expressed high 
PAF protein levels (MFI = 11,434).1760 Paf controls HSC function and development | Amrani et al.
Figure 2.  Paf restricts HSC and progenitor cycling and protects LMPPs and CLPs from p53-mediated apoptosis. (A) PAF protein levels in BM 
HSC and progenitor populations relative to cell cycle (DAPI). Data are presented as an overlay of PAF staining obtained for each population from Paf+/+ 
and Paf/ mice. Numbers in parentheses are the MFI obtained for PAF. Horizontal light blue line highlights the differences in PAF expression among the 
populations. LSK cells were separated into MEPs (CD34) and a population containing CMPs and GMPs (CD34+). (B) Percentage of BM Paf+/+ and Paf/ 
HSC and progenitors that are in the S–G2–M phases of the cell cycle. Representative FACS profiles are shown in Fig. S2 D. (C) Representative staining 
profiles of Paf+/+ and Paf/ BM cells from mice that were injected 24 h earlier with BrdU. The BrdU+ gate was established by using BM from PBS-injected JEM Vol. 208, No. 9  1761
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negatively associated with LT-HSC self-renewal (Pervaiz et al., 
2009). Consistent with this, Paf/ LT-HSCs displayed higher 
levels of ROS than Paf+/+ LT-HSCs (Fig. 3 C). In vivo treat-
ment of Paf/ mice with the antioxidant N-acetylcysteine 
(NAC) restored progenitor development (Fig. 3, D and E). 
When compared with progenitors from NAC-treated Paf+/+ 
mice, the frequency of Paf/ ST-HSCs was significantly de-
creased, whereas MPPs and LMPPs were significantly increased. 
This resulted in a significant increase in the absolute number 
of LMPPs in the BM of NAC-treated Paf/ mice (Fig. S3 D). 
Thus, the increased ROS levels observed for Paf/ LT-HSC 
were functionally relevant.
and Fig. S3 A). There were 3-fold more Paf/ than Paf+/+ 
LT-HSCs in the resting G1 phase of the cell cycle, whereas 
there  were  1.7-,  2-,  and  1.2-fold  more  ST-HSCs, 
MPPs, and LMPPs, respectively (Fig. 3, A and B; and Fig. 
S3 A). Thus, Paf deficiency had a greater impact on the qui-
escence status of LT-HSCs than on other LSK subsets. Simi-
lar results were observed when cell cycle status was measured 
using Pyronin Y and Hoechst 33342 staining (Fig. S3, B and C). 
These data show that LT-HSCs from Paf/ mice fail to main-
tain quiescence.
The loss of LT-HSC quiescence frequently correlates with 
increased cellular reactive oxygen species (ROS), which is 
mice (Fig. S2 E). (D) Percentage of each BM subset that incorporated BrdU. (E) Representative FACS analyses of HSC subsets showing Annexin V versus 
DAPI staining. Gating of apoptotic cells (AnnexinV+DAPI) was determined as shown in Fig. S2 F. (F) Cumulative data showing the percentage of cells 
undergoing apoptosis. (G) Representative staining profiles for LT-HSC, ST-HSC, MPP, and LMPP from Paf+/+p53+/+, Paf+/+p53+/, Paf/p53+/+, and  
Paf/p53+/ mice. (H) Cumulative data showing the LMPP frequency (left) and absolute cell numbers (right). Data were combined from 3–8 experiments 
on 1–2 mice/genotype. Each symbol represents a mouse, and horizontal bars mark the mean. *, P < 0.05; **, P < 0.01; ***, P < 0.001.
 
Figure 3.  Disruption of HSC quiescence in the absence of Paf. (A) Representative staining profiles for LSK and LT-HSC analyzed for Ki-67 and 
cell cycle (DAPI). (B) Cumulative data showing the percentage of cells in each BM subset that are quiescent (G0), resting (G1), or cycling (S–G2–M).  
(C) Representative histograms showing Lin BM LT-HSCs loaded with the ROS detection reagent, 5-(and-6)-carboxy-2’,7’-difluorodihydrofluorescein 
diacetate. The gate shows the percentage of ROS+ cells. Cumulative data shows the fold difference in percentage of ROS positive LT-HSCs for  
Paf/ relative to Paf+/+ LT-HSCs. (D) Representative FACS profiles for BM subsets from NAC-treated or control mice. (E) Cumulative data showing  
the frequency of each population as a percentage of the LSK gate from (D). Absolute cell numbers are shown in Fig. S3 D. Data were combined from 
3–4 individual experiments of 1–3 mice/genotype. Each symbol represents a mouse and horizontal bars indicate the mean. *, P < 0.05; **, P < 0.01;  
***, P < 0.001.1762 Paf controls HSC function and development | Amrani et al.
Paf maintains the LT-HSC pool and controls HSC  
progenitor development
To determine if Paf deficiency altered the functional compe-
tence of HSCs, the competitive repopulating ability of Paf/ 
BM cells was measured. Paf/ and WT B6.SJL Lin BM was 
mixed at a 1:1 or a 9:1 (Paf//WT) ratio and transferred into 
lethally irradiated B6 x B6.SJL F1 recipients (Fig. S3E). The 
contribution of Paf/ HSCs to hematopoiesis was moni-
tored by FACS analysis of PBLs over 18 wk (Fig. 4 A). In 1:1 
transplanted mice, Paf/ HSCs did not contribute to hemato-
poiesis (<1%). However, in the 9:1 transplanted mice, a small 
fraction of granulocytes (5.1 ± 2.2), B cells (3.9 ± 1.7) and   
T cells (5.3 ± 1.7) were derived from Paf/ HSCs at   
6 wk. Reduced, but detectable levels of Paf/ granulocytes 
(1.4 ± 0.8), B cells (2.0 ± 1.0) and T cells (1.7 ± 0.6) re-
mained at 18 wk. Hematopoiesis at 16 wk post-transplant is 
derived  from  LT-HSCs  (Dykstra  et  al.,  2007). Therefore, 
Paf/ HSCs were not only compromised in their ability to 
mediate ST hematopoiesis, but were also unable to mediate 
LT  repopulation. These  studies  also  show  that  Paf  defi-
ciency compromises HSC development and function in a 
cell-intrinsic manner.
The inability of Paf/ HSCs to contribute to hemato-
poiesis might be caused by the inability to home to hemato-
poietic niches of the BM. Although at 20 wk post-transplant 
LSKs were preferentially derived from WT cells (76.3.7 ± 
19.4%) Paf/ cells were also present (Fig. 4, B and C). Paf/ 
cells made the largest contribution to the LT-HSC subset and 
the percentage of Paf/ cells contributing to each develop-
ing subset decreased as the cells differentiated from LT-HSCs 
to LMPPs (Fig. 4, B and C). Reconstitution of myeloery-
throid progenitors by Paf/ cells was also diminished relative 
to LT-HSCs, but less impacted than LMPPs, which were 
undetectable in all but one mouse. Thus, when Paf/ HSCs 
are placed in the same host environment as WT HSCs, Paf/ 
deficient LT-HSCs engraft, but continue to display a prefer-
entially impaired ability to generate MPPs and LMPPs. These 
data establish Paf/ as a cell-intrinsic factor critical for HSC 
progenitor development, differentiation, and function.
Our  data  show  that  Paf  controls  LT-HSC  quiescence. 
However, the need to replenish the leukopenic periphery of 
Paf/ mice could potentially drive LT-HSCs out of quies-
cence. At 20 wk after transplant, LSKs and LSKs derived 
from Paf/ and WT cells in the BM of the 9:1 recipient mice 
Figure 4.  Paf/ HSCs are functionally compromised. (A) Peripheral 
blood from lethally irradiated mice transplanted with a 1:1 (n = 5) or 9:1 
(n = 6) mix of Lin BM from Paf / (CD45.2) and WT (CD45.1) donor 
mice were monitored for the contribution of Paf +/+ and Paf / HSCs to 
the granulocyte, T and B cell lineages. Data show mean ± SD and are rep-
resentative of two identical experiments. (B) Representative FACS analysis 
of BM HSC populations at 20 wk after transplant for 9:1 BM-transplanted 
mice. (C) Cumulative data from B. Data were pooled from analyses  
of three mice/genotype for two independent chimera experiments.  
(D) Cumulative data showing the percentage of cycling cells in the BM of 9:1 
transplanted mice (representative FACS plots are shown in Fig. S3 F). Data 
pooled for two mice from two independent experiments. (E) Paf/ BM 
cells are defective in rescuing lethally irradiated recipients after a second 
transplant. Survival curves for recipients of secondary BM transplants. 
Data combined from two independent experiments of 10 mice/genotype 
each. (F) The number of cobblestone area forming cells in Lin Paf+/+ and 
Paf/ BM was determined by scoring colonies at 21 d. Data shown are 
means of two similar experiments ± SD of 1 mouse/genotype. *, P < 0.05; 
**, P < 0.01; ***, P < 0.001.
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software (Tree Star). Cell doublets were excluded from all analyses and, when 
possible, dead cells were excluded by the use of DAPI. For BM and spleno-
cyte preparations, RBCs were lysed before antibody staining. For intracellular 
Ki-67 or PAF staining, Lin cells were enriched using a Lineage Cell Depletion 
kit (Miltenyi Biotec), stained for cell surface markers, fixed, and made perme-
able with an intracellular staining buffer set (eBioscience) or with ice-cold 
methanol, and then stained with specific antibody or isotype control. For cell 
cycle analysis, fixed and permeabilized cells were incubated with 10 µg/ml DAPI 
before analysis. ROS levels were measured by suspending Lin BM in warm 
PBS containing and 5 µM 5-(and-6)-carboxy-2’,7’-difluorodihydrofluorescein 
diacetate. After incubation at 37°C for 15 min, cells were washed, surface 
stained to identify LT-HSCs, and analyzed by FACS.
The following antibodies (all from eBioscience or BD) conjugated to 
FITC, Alexa Fluor 488, PE, PE-Cy7, APC, Alexa Fluor 647, APC-Alexa 
Fluor 750, APC-Alexa Fluor-780, PercpCy5.5, Pacific Blue, Alexa Fluor 700, 
or PE-Cy5 were use for the flow cytometric analyses: -CD3 (145-2C11), 
-CD4 (RM4-5), -CD8 (53–6.7), -NK1.1 (PK136), -CD19 (1D3), -CD11c 
(N418), -CD11b (M1/70), -TCR (H57 597), -TCR (GL3), –Gr-1(RB6-
8C5), -TER119 (TER-119), -CD25 (PC61), -CD44 (IM7), –c-Kit (2B8),   
–Flt-3 (A2F10.1), –Sca-1 (D7), -CD34 (RAM34), and –IL-7R (A7R34).   
A table listing all antibodies, lineage cocktails, and combinations of mAbs used to 
identify each progenitor population analyzed is presented in Tables S1 and S2.
Generation of PAF-specific mAbs Armenian hamster mAbs specific for 
Paf were generated by the Monoclonal Antibody Core Facility of Memorial 
Sloan-Kettering Cancer Center (MSKCC) with standard approaches after 
immunization of animals with a GST-Paf fusion protein emulsified in Titer-
max. The specificity of two Paf-specific mAbs (called Jyld12 and Jyld15) was 
determined by flow cytometry, immunofluorescence, and Western blotting of 
CHO cells transfected with Paf or empty vector and also with lymphocytes 
derived from Paf+/+ and Paf/ mice (Fig. S2 A). The -Paf mAb, Jyld12, was 
produced, purified, and conjugated to Alexa Fluor 488 by the Monoclonal 
Antibody Core Facility of MSKCC.
Gene targeting and mice. Paf/ mice on the C57BL/6 background were 
generated using standard techniques as follows. A 436-bp NotI–BgII fragment 
ranging from 36 bp upstream of the Paf ATG in exon I to the HindIII site (de-
stroyed), downstream of exon II, was generated by PCR and cloned into the 
pL451 vector using NotI and BamHI sites. The resultant plasmid was digested 
with RsaI and EcoRI to release an exon I–II fragment flanked by a Loxp site 
downstream of exon II. This fragment was subcloned into pL451 that had been 
digested with NotI and HindIII together with a 190-bp PCR fragment cover-
ing the rest of the 5-UTR of exon I and extending to 15 bp upstream of the 
XhoI site and the Loxp-FRT-Neo-FRT cassette (from pL451) in a 4-piece   
ligation reaction. Finally, a 3.9-Kb XhoI–SalI PCR-generated fragment start-
ing at the destroyed HindIII site downstream of exon II was cloned into the 
SalI site of the latter plasmid. The 2.4-Kb genomic DNA containing the in-
serted LoxP site and the LoxP-FRT-Neo-FRT cassette were released and suc-
cessfully used for BAC recombineering to generate the BAC targeting vector. 
The RP23-177B-17 BAC clone containing the Paf locus was transformed into 
SW105, which was subsequently transformed with the 6.5-Kb genomic frag-
ment mentioned above and activated for recombination (Lee et al., 2001; Liu 
et al., 2003). A DTA-AMP–negative selection cassette (from pKOSelectDT-
840) was generated by PCR using hybrid primers containing genomic DNA 
sequences located upstream and downstream of the genomic region comple-
mentary to screening probe A (Fig. S1 B). The flanked DTA-AMP cassette was 
inserted into the RP23-177B-17 BAC containing the LoxP-FRT-Neo-FRT 
cassette by recombination to generate the BAC targeting vector. All fragments 
were sequenced to verify that mutations were not introduced. The BAC tar-
geting vector DNA was purified using a QIAGEN BAC purification kit and 
used to target the Paf genomic locus of the CY2.4 ES parental cell line, derived 
from C57BL/6J-Tyr (c-2J) embryos, by the Gene Targeting Resource Center 
of The Rockefeller University. G418-resistant clones were screened by ge-
nomic Southern blot hybridization. Out of 96 clones, 32 were shown to have 
undergone homologous recombination at the Paf locus.
had similar cell cycle profiles (Fig. 4 D and Fig. S3 F). How-
ever, there was a significant increase in the percentage of 
Paf/ LT-HSCs residing in the S–G2–M phases of the cell 
cycle (1.7-fold). Paf/ MPPs also had a significantly increased 
percentage of cycling cells (1.2-fold). Thus, the cell cycle 
status of progenitor populations was, for the most part, nor-
malized in the nonleukopenic environment of the chimeric 
hosts; however, LT-HSCs continued to disproportionally cycle. 
Collectively, these analyses support that Paf is essential for the 
maintenance  of  LT-HSC  quiescence.  However,  progenitor 
proliferation in the BM of Paf/ mice is likely caused by the 
need to replenish the leukopenic periphery and not directly 
caused by the loss of Paf.
The loss of LT-HSC quiescence often results in the loss of 
self-renewal potential. The self-renewal potential of Paf/ 
HSCs was tested by serial BM transplantation under non-
competitive conditions. Lin BM from Paf+/+ or Paf/ mice 
rescued all lethally irradiated primary recipients. However, 
upon secondary transfer, Paf/ BM protected only 30% of 
the secondary recipients from death, whereas nearly all the 
Paf+/+ recipients survived (Fig. 4 E). Thus, Paf/ HSCs have 
reduced self-renewal potential. Finally, Paf/ HSC function 
was tested with an in vitro cobblestone area-forming cell 
(CAFC) assay, an assay that identifies LT-HSCs (Breems et al., 
1994). Lin Paf/ BM cells showed an 20-fold reduction 
in wk 3 CAFCs compared with Paf+/+ cells (Fig. 4 F). Collec-
tively, our data shows that Paf has a pivotal role in maintaining 
the LT self-renewal potential of HSCs.
Despite being an active and clinically relevant area of re-
search, the mechanisms that regulate HSC self-renewal and 
differentiation remain unclear. Excessive cycling of LT-HSCs 
eventually leads to premature exhaustion and loss of self- 
renewal. Thus, tight regulation of the cell cycle in LT-HSC is 
an important mechanism that contributes to ensure proper 
LT-HSC function. Studies have implicated cyclin-dependent 
kinases and their inhibitors, transcriptional regulators, and sig-
naling proteins as being important for proper cell cycle con-
trol in LT-HSCs (Walkley et al., 2005; Jude et al., 2008). How 
these pathways interact at a molecular level to orchestrate the 
delicate balance between LT-HSC quiescence and prolifera-
tion remains an open question. Our studies demonstrate that 
Paf protects LT-HSCs from exhaustion through the mainte-
nance  of  cellular  quiescence,  thus  ensuring  LT-HSC  self- 
renewal and functional integrity. The identification of Paf as 
necessary for proper cell cycle regulation of LT-HSCs pro-
vides additional molecular insight into HSC biology and rein-
forces the tight linkage between LT-HSC function, progenitor 
development, and proper cell cycle control.
MATERIALS AND METHODS
FACS  and  antibodies. BM single-cell suspensions were prepared from   
1 tibia and femur for HSC subset analysis or from 2 tibias, femurs, pelvis, 
humerus, radius, and shoulder plates for cell cycle, Pyronin Y, BrdU, PAF, and 
Ki-67 analyses. Single-cell suspensions from hematopoietic organs were in-
cubated with Fc receptor-blocking antibody (clone 2.4G2) before being 
stained on ice with specific antibodies conjugated to different fluorophores. 
Data were acquired on a LSR II cytometer (BD) and analyzed using FlowJo 1764 Paf controls HSC function and development | Amrani et al.
Bruff’s medium supplemented with 10% FBS. Cells were >80–95% pure as 
accessed by FACS. At 3, 24, and 48 h, cells were stained with Alexa Fluor 
488–conjugated Annexin V (Invitrogen) and DAPI according to the supplied 
protocol and analyzed by FACS analysis. Apoptotic cells were defined as 
AnnexinV+, DAPI.
Pyronin Y staining. Enriched Lin BM cells were surface stained, fixed, 
and permeabilized with Cytofix/Cytoperm solution (BD), and cells (2 × 106 
cells/ml  in  PBS)  were  incubated  at  room  temperature  for  45  min  with 
Hoechst 33342 (2 mM, Sigma) followed by a 45 min incubation with Pyro-
nin Y (0.5 mm, SIGMA).
In vivo treatment of mice with NAC. Cohorts of Paf+/+ and Paf/ mice 
received 1 mg/ml NAC in the drinking water for 2 wk, and 500 mg/kg i.p. 
in saline daily for the last 7 d of the two weeks. Control mice were fed auto-
claved water and received saline i.p. for the last 7 d.
In vitro HSC assay. The number of CAFC was determined as previously 
described (Breems et al., 1994). In brief, Lin BM or spleen cells from Paf+/+ 
(4 × 103 BM or 105 splenocytes) and Paf/ (2.5 × 104 BM or 106 spleno-
cytes) mice were plated in duplicate in T12.5 tissue-culture flasks (Becton 
Dickinson) containing confluent monolayers of MS5 cells. Cobblestone areas 
≤10 phase-dark closely associated cells beneath the stroma were scored at   
day 21 as CAFC.
Serial  BM  transplantation. Lin BM cells from 11-mo-old Paf+/+ or 
Paf/ (CD45.2) mice were transplanted by i.v injection (105 cells/recipient) 
into lethally irradiated B6.SJL mice (CD45.1; n = 10 each). For irradiation, 
1,300 Rads of total body irradiation were administered as a split dose with a 
3–4-h interval between doses. 16 wk after transplantation, BM cells were 
harvested from the Paf+/+ or Paf/ primary recipient mice and transplanted 
into new cohorts (n = 10 each) of lethally irradiated B6.SJL recipient mice. 
Mice were monitored and scored for mortality during the next 60 d.
Statistics. The unpaired, two-tailed Student’s t test was used for statistical 
confirmation of differences between experimental group means (P < 0.05) 
for most experiments. For the data shown in Fig. 2 F into Fig. 4 (C and D), 
paired t tests were used. Data were analyzed using GraphPad Prism 5.
Online supplemental material. Fig. S1 shows the targeting strategy 
used to generate Paf/ mice. Fig. S2 demonstrates the specificity of PAF- 
specific mAbs that were generated for these studies. Fig. S3 shows represen-
tative FACS analysis for HSC subsets stained with Ki-67 and DAPI. Tables 
S1 and S2 show the surface markers used to identify progenitor popula-
tions studies and the antibody-fluorophore combinations used for the each 
experiment. Online supplemental material is available at http://www.jem 
.org/cgi/content/full/jem.20102170/DC1.
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